Exane Derivatives Boston Scientific Corp Transaction History

Exane Derivatives

$157 Million
Q2 2022

A detailed history of Exane Derivatives transactions in Boston Scientific Corp stock. As of the latest transaction made, Exane Derivatives holds 43,067 shares of BSX stock, worth $4.53 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

43,067

Previous 45,926 6.23%

Holding current value

$4.53 Million

Previous $2.03 Million 21.09%

% of portfolio

1.03%

Previous 0.63%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$35.24 - $47.1 $100,751 - $134,658	-2,859 Reduced 6.23%	43,067 $1.61 Million
Q1 2022 Apr 22, 2022	SELL	$40.9 - $45.1 $141,473 - $156,000	-3,459 Reduced 7.0%	45,926 $2.03 Million
Q4 2021 Jan 28, 2022	SELL	$38.07 - $44.87 $1.79 Million - $2.11 Million	-47,037 Reduced 48.78%	49,385 $2.1 Million
Q3 2021 Oct 26, 2021	SELL	$41.23 - $45.88 $152,344 - $169,526	-3,695 Reduced 3.69%	96,422 $4.18 Million
Q2 2021 Jul 28, 2021	BUY	$38.58 - $44.24 $299,187 - $343,081	7,755 Added 8.4%	100,117 $4.28 Million
Q1 2021 Apr 30, 2021	SELL	$35.27 - $39.67 $578,921 - $651,143	-16,414 Reduced 15.09%	92,362 $3.57 Million
Q4 2020 Jan 27, 2021	BUY	$33.15 - $41.97 $365,445 - $462,677	11,024 Added 11.28%	108,776 $3.91 Million
Q3 2020 Oct 06, 2020	SELL	$34.44 - $42.23 $666,551 - $817,319	-19,354 Reduced 16.53%	97,752 $3.74 Million
Q2 2020 Jul 10, 2020	SELL	$30.19 - $39.11 $49,149 - $63,671	-1,628 Reduced 1.37%	117,106 $4.11 Million
Q1 2020 Apr 17, 2020	BUY	$25.83 - $45.71 $1.06 Million - $1.87 Million	40,954 Added 52.65%	118,734 $3.87 Million
Q4 2019 Jan 22, 2020	BUY	$37.87 - $45.37 $1.34 Million - $1.61 Million	35,416 Added 83.6%	77,780 $3.52 Million
Q3 2019 Oct 15, 2019	SELL	$40.31 - $43.45 $64,415 - $69,433	-1,598 Reduced 3.63%	42,364 $1.72 Million
Q2 2019 Jul 12, 2019	BUY	$34.91 - $42.98 $330,911 - $407,407	9,479 Added 27.49%	43,962 $0
Q1 2019 Apr 24, 2019	BUY	$32.91 - $40.75 $1.1 Million - $1.36 Million	33,319 Added 2862.46%	34,483 $0
Q4 2018 Jan 31, 2019	BUY	$31.73 - $39.04 $36,901 - $45,403	1,163 Added 116300.0%	1,164 $41,000
Q3 2018 Oct 24, 2018	SELL	$32.83 - $38.63 $13,328 - $15,683	-406 Reduced 99.75%	1 $0
Q2 2018 Jul 19, 2018	SELL	$26.84 - $34.32 $48,365 - $61,844	-1,802 Reduced 81.58%	407 $0
Q1 2018 Apr 30, 2018	SELL	$25.2 - $28.54 $13,456 - $15,240	-534 Reduced 19.47%	2,209 $0
Q4 2017 Jan 29, 2018	BUY	$24.79 - $29.8 $67,428 - $81,056	2,720 Added 11826.09%	2,743 $0
Q3 2017 Oct 18, 2017	BUY	$26.26 - $29.17 $603 - $670	23	23 $0

Others Institutions Holding BSX

# of Institutions

1,832

Shares Held

1.21B

Call Options Held

9.66M

Put Options Held

6.98M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $151B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account

Exane Derivatives Boston Scientific Corp Transaction History